{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:13:36Z","timestamp":1790802816863,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03671-z","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:55:59Z","timestamp":1762167359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS study"],"prefix":"10.1186","volume":"27","author":[{"given":"Andrea","family":"Picchianti Diamanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Paci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Maria","family":"Luchetti Gentiloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria Anna","family":"Bellofatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Falsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"D\u2019Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Crepaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alen","family":"Zabotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Canzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Domenico","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Scirocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Iagnocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"3671_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, Landew\u00e9 R, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease- modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82:3\u201318. https:\/\/doi.org\/10.1136\/ard-2022-223356.","journal-title":"Ann Rheum Dis"},{"key":"3671_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11926-019-0821-1","volume":"21","author":"MMP Verhoeven","year":"2019","unstructured":"Verhoeven MMP, Welsing PMJ, Bijlsma JWJ, et al. Effectiveness of remission induction strategies for early rheumatoid arthritis: a systematic literature review. Curr Rheumatol Rep. 2019;21:24. https:\/\/doi.org\/10.1007\/s11926-019-0821-1.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"3671_CR3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/acr.23016","volume":"69","author":"P Hamann","year":"2017","unstructured":"Hamann P, Holland R, Hyrich K, et al. Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor. Arthritis Care Res (Hoboken). 2017;69(6):783\u201393. https:\/\/doi.org\/10.1002\/acr.23016.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"3671_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1759720X17720366","volume":"9","author":"S Ajeganova","year":"2017","unstructured":"Ajeganova S, Huizinga T. Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations. Ther Adv Musculoskel Dis. 2017;9(10):249\u201362. https:\/\/doi.org\/10.1177\/1759720X17720366.","journal-title":"Ther Adv Musculoskel Dis"},{"key":"3671_CR5","doi-asserted-by":"publisher","first-page":"e003196","DOI":"10.1136\/rmdopen-2023-003196","volume":"9","author":"MA Messelink","year":"2023","unstructured":"Messelink MA, den Broeder AA, Marinelli FE, Michgels E, Verschueren P, Aletaha D, et al. What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis. RMD Open. 2023;9:e003196.","journal-title":"RMD Open"},{"key":"3671_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00296-015-3415-x","volume":"36","author":"PC Taylor","year":"2016","unstructured":"Taylor PC, Moore A, Vasilescu R, Alvir J, Tarallo M. A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective. Rheumatol Int. 2016;36:685\u201395.","journal-title":"Rheumatol Int"},{"key":"3671_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13075-019-2059-8","volume":"21","author":"V Strand","year":"2019","unstructured":"Strand V, Schiff M, Tundia N, et al. Effects of Upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs. Arthritis Res Ther. 2019;21:263. https:\/\/doi.org\/10.1186\/s13075-019-2059-8.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"3671_CR8","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/art.41032","volume":"71","author":"R Fleischmann","year":"2019","unstructured":"Fleischmann R, Pangan AL, Song IH, et al. Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III, double-blind randomized controlled trial. Arthritis Rheumatol. 2019;71(11):1788\u2013800. https:\/\/doi.org\/10.1002\/art.41032.","journal-title":"Arthritis Rheumatol"},{"issue":"10139","key":"3671_CR9","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/S0140","volume":"391","author":"GR Burmester","year":"2018","unstructured":"Burmester GR, Kremer JM, Van de Bosch F, et al. Safety and efficacy of Upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391(10139):2503\u201312. https:\/\/doi.org\/10.1016\/S0140-.","journal-title":"Lancet"},{"key":"3671_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40744-024-00651-8","volume":"11","author":"L Bessette","year":"2024","unstructured":"Bessette L, Chan J, Chow A, Lisnevskaia L, Richard N, et al. Real-World effectiveness of Upadacitinib for treatment of rheumatoid arthritis in Canadian patients: interim results from the prospective observational CLOSE-UP study. Rheumatol Ther. 2024;11:563\u201382. https:\/\/doi.org\/10.1007\/s40744-024-00651-8.","journal-title":"Rheumatol Ther"},{"key":"3671_CR11","doi-asserted-by":"publisher","unstructured":"\u00d6st\u00f6r A, Feist E, Sidiropoulos P, Avouac J, Rebella M, et al. Achievement of treatment targets and maintenance of response with Upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study. Arthritis Res Therapy. 2025;2784. https:\/\/doi.org\/10.1186\/s13075-025-03528-5.","DOI":"10.1186\/s13075-025-03528-5"},{"key":"3671_CR12","doi-asserted-by":"publisher","unstructured":"Baldi C, Gentileschi S, Li Gobbi F, Cazzato M, Delle Sedie A, et al. Real-world effectiveness and retention rate of Upadacitinib in patients with rheumatoid arthritis: results from a multicentre study. Clin Experimental Med. 2025;25(50). https:\/\/doi.org\/10.1007\/s10238-025-01578-2.","DOI":"10.1007\/s10238-025-01578-2"},{"key":"3671_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40744-024-00736-4","volume":"12","author":"P Youssef","year":"2025","unstructured":"Youssef P, Ciciriello S, Tahir T, Leadbetter J, Butcher B, et al. Real\u2013World persistence and effectiveness of Upadacitinib versus other Janus kinase inhibitors and tumor necrosis factor inhibitors in Australian patients with rheumatoid arthritis. Rheumatol Ther. 2025;12:173\u2013202. https:\/\/doi.org\/10.1007\/s40744-024-00736-4.","journal-title":"Rheumatol Ther"},{"key":"3671_CR14","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1093\/rheumatology\/kead543","volume":"63","author":"S Hayashi","year":"2024","unstructured":"Hayashi S, Tachibana S, Maeda T, Yamashita M, Shirasugi I, et al. Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study. Rheumatology. 2024;63:3033\u201341. https:\/\/doi.org\/10.1093\/rheumatology\/kead543.","journal-title":"Rheumatology"},{"issue":"1","key":"3671_CR15","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/ar4132","volume":"15","author":"DF Ten Cate","year":"2013","unstructured":"Ten Cate DF, Luime JJ, Swen N, et al. Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis - a systematic review of the literature. Arthritis Res Ther. 2013;15(1):R4. https:\/\/doi.org\/10.1186\/ar4132.","journal-title":"Arthritis Res Ther"},{"key":"3671_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/rheumatology\/ket405","volume":"53","author":"SY Kawashiri","year":"2014","unstructured":"Kawashiri SY, Suzuki T, Nakashima Y, et al. Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power doppler subclinical synovitis is associated with bone erosion. Rheumatology (Oxford). 2014;53:562\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/ket405.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3671_CR17","first-page":"984","volume":"36","author":"A Picchianti Diamanti","year":"2018","unstructured":"Picchianti Diamanti A, Navarini L, Messina F, et al. Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints. Clin Exp Rheumatol. 2018;36(6):984\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"3671_CR18","doi-asserted-by":"publisher","unstructured":"Colebatch AN, Edwards CJ, \u00d8stergaard M et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis.2013;72:804\u201314. https:\/\/doi.org\/10.1136\/annrheumdis- 2012- 203158.","DOI":"10.1136\/annrheumdis-"},{"key":"3671_CR19","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/rheumatology\/keu211","volume":"53","author":"P Mandl","year":"2014","unstructured":"Mandl P, Kurucz R, Niedermayer D, et al. Contributions of ultrasound beyond clinical data in assessing inflammatory disease activity in rheumatoid arthritis: current insights and future prospects. Rheumatology (Oxford). 2014;53:2136\u201342. https:\/\/doi.org\/10.1093\/rheumatology\/keu211.","journal-title":"Rheumatology (Oxford)"},{"key":"3671_CR20","first-page":"49","volume":"35","author":"L Terslev","year":"2008","unstructured":"Terslev L, von der Recke P, Torp-Pedersen S, et al. Diagnostic sensitivity and specificity of doppler ultrasound in rheumatoid arthritis. J Rheumatol. 2008;35:49\u201353.","journal-title":"J Rheumatol"},{"key":"3671_CR21","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1136\/ard.2005.044628","volume":"65","author":"E Filippucci","year":"2006","unstructured":"Filippucci E, Iagnocco A, Salaffi F, et al. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis. 2006;65:1433\u20137. https:\/\/doi.org\/10.1136\/ard.2005.044628.","journal-title":"Ann Rheum Dis."},{"key":"3671_CR22","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1002\/art.23682","volume":"58","author":"E Naredo","year":"2008","unstructured":"Naredo E, Moller I, Cruz A, et al. Power doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2008;58:2248\u201356. https:\/\/doi.org\/10.1002\/art.23682.","journal-title":"Arthritis Rheum"},{"key":"3671_CR23","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1093\/rheumatology\/keac261","volume":"61","author":"E Silvagni","year":"2022","unstructured":"Silvagni E, Zandonella Callegher S, et al. Musculoskeletal ultrasound for treating rheumatoid arthritis to target\u2014a systematic literature review. Rheumatology. 2022;61:4590\u2013602.","journal-title":"Rheumatology"},{"key":"3671_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/jcm13020401","volume":"13","author":"C Baldi","year":"2024","unstructured":"Baldi C, Parisi S, Falsetti P, Sota S, Ditto MC, et al. Efficacy and safety of Upadacitinib in rheumatoid arthritis: Real-Life experience from a prospective longitudinal multicentric study. J Clin Med. 2024;13:401. https:\/\/doi.org\/10.3390\/jcm13020401.","journal-title":"J Clin Med"},{"key":"3671_CR25","doi-asserted-by":"publisher","unstructured":"Picchianti Diamanti A, Cattaruzza MS, Salemi S, Di Rosa R, Sesti G et al. Clinical and ultrasonographic remission in Bio\u2013na.ve and Bio\u2013failure patients with rheumatoid arthritis at 24 weeks of Upadacitinib treatment: the UPARAREMUS Real\u2013Life study. Rheumatol Ther https:\/\/doi.org\/10.1007\/s40744-024-00712-y","DOI":"10.1007\/s40744-024-00712-y"},{"key":"3671_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/art.20939","volume":"52","author":"AK Scheel","year":"2005","unstructured":"Scheel AK, Hermann K-GA, Kahler E, et al. A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2005;52:733\u201343. https:\/\/doi.org\/10.1002\/art.20939.","journal-title":"Arthritis Rheum"},{"key":"3671_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/art.10877","volume":"48","author":"M Szkudlarek","year":"2003","unstructured":"Szkudlarek M, Court-Payen M, Jacobsen S, et al. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum. 2003;48:955\u201362. https:\/\/doi.org\/10.1002\/art.10877.","journal-title":"Arthritis Rheum"},{"key":"3671_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3899\/jrheum","volume":"46","author":"AB Bruyn","year":"2019","unstructured":"Bruyn AB, Iagnocco A, Naredo E, et al. OMERACT definitions for ultrasonographic pathology and elementary lesions of rheumatic disorders fifteen years on. J Rheumatol. 2019;46:10. https:\/\/doi.org\/10.3899\/jrheum.","journal-title":"J Rheumatol"},{"key":"3671_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/art","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, Van\u2019t Hof MA, Kuper HH, et al. Modified disease activity scores that include twentyeight- joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:448. https:\/\/doi.org\/10.1002\/art. 17803 80107.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"3671_CR30","doi-asserted-by":"publisher","first-page":"i86","DOI":"10.1136\/annrheumdis-2011-200618","volume":"71","author":"D Felson","year":"2012","unstructured":"Felson D. Defining remission in rheumatoid arthritis. Ann Rheum Dis. 2012;71(Suppl 2):i86-8. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200618.","journal-title":"Ann Rheum Dis."},{"key":"3671_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology. 2003;42:244\u201357. https:\/\/doi.org\/10.1093\/rheumatology\/.","journal-title":"Rheumatology"},{"key":"3671_CR32","doi-asserted-by":"publisher","unstructured":"Boyadzhieva V, Tachkov K, Emin S, Apostolova Z, Stoilov R. Ultrasound evaluation of therapeutic response to Tofacitinib and Upadacitinib in patients with rheumatoid arthritis Real-Life clinical data. Biomedicines. 2025;131339. https:\/\/doi.org\/10.3390\/biomedicines13061339.","DOI":"10.3390\/biomedicines13061339"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03671-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03671-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03671-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:56:00Z","timestamp":1762167360000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03671-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3671"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03671-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6812552\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethic Committee of the Coordinator Centre (Lazio area 1, Approval numbers 6493_2021 on June 15, 2021) and by each Centre participating in the study; a written informed consent was obtained from all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}